Leducq Foundation Leducq Foundation Leducq Foundation Leducq Foundation
  • About
    • Leducq Organization
    • History
    • Leadership
  • Networks of Excellence
    • How to Apply
    • Funded Networks
    • Policies & Documents
  • Rheumatic Heart Disease
    • Acute Rheumatic Fever Biomarker Project
    • Group A Strep – Immune Correlates of Protection
      • Application Instructions
      • Application Timetable 2022-2023
    • Group A Strep Vaccine Development
    • Polymeric Heart Valve
    • Policies & Documents
  • News
    • Latest Developments
    • Subscribe
  • Contact
    • Leducq Organization
Leducq Foundation Leducq Foundation
  • About
    • Leducq Organization
    • History
    • Leadership
  • Networks of Excellence
    • How to Apply
    • Funded Networks
    • Policies & Documents
  • Rheumatic Heart Disease
    • Acute Rheumatic Fever Biomarker Project
    • Group A Strep – Immune Correlates of Protection
      • Application Instructions
      • Application Timetable 2022-2023
    • Group A Strep Vaccine Development
    • Polymeric Heart Valve
    • Policies & Documents
  • News
    • Latest Developments
    • Subscribe
  • Contact
    • Leducq Organization

2022

Leducq Foundation

AtheroGEN

Cardiovascular disease causes 51% of deaths in women and 42% of deaths in men in Europe. Women account for a greater proportion of increased hospitalizations for coronary artery disease (CAD)... read more →
  • June 13, 2022
  • Jake Powers

Cellular and Molecular Drivers of Acute Aortic Dissections

The natural history of aneurysms involving the first portion of the aorta is to asymptomatically enlarge over time until a sudden tear in the inner layer of the aortic wall... read more →
  • June 13, 2022
  • Jake Powers

CHECKPOINT ATHERO

Immunotherapy has revolutionized the way cancer patients that were previously deemed incurable can be treated. Patients with solid tumors are now being successfully treated with antibodies against inhibitory immune checkpoints,... read more →
  • June 13, 2022
  • Jake Powers

International Network of Excellence on Brain Endothelium: A Nexus for Cerebral Small Vessel Disease

Small vessel disease (SVD) is a major cause of microinfarcts and microbleeds—types of stroke that often go undetected, but are major contributors to disability and dementia. Brain endothelial cells (BECs)... read more →
  • June 13, 2022
  • Jake Powers

SUBSCRIBE

Please join our mailing list to receive information regarding grant information, research highlights, and more.

Subscribe Now

CONTACT

BOSTON

265 Franklin Street, Suite 1902
Boston, Massachusetts 02110

PHONE: +1 617.459.4688
EMAIL: contact@flcq.org

Contact Us
© 2005-[Y] The Leducq Foundation. All Rights Reserved. Home | Contact | Sitemap | Privacy Policy